True, but I think it's well and truly accepted/proven that the commercial reward from investing in intellectual property rights, far outweighs the risk of not being able to finance their enforcement.
This company would have very few (intelligent) investors if they weren't bothering to patent the product.
Ann: Canadian Patent Granted for RECCE Anti-Infectives, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.005(0.94%) |
Mkt cap ! $124.0M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.5¢ | 52.0¢ | $46.52K | 88.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52000 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 34072 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |